Delivery Order SPE2DB22D2206-SPE2DB24FKL92

Award Date 9/25/24
Potential Completion Date 9/26/24
Potential Value $8.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of "SODIUM PHOSPHATE 15 MMOL/5 ML 5ML" to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is a Delivery Order valued at $2,008.91 with a firm fixed price. It has an ultimate completion date of April 12, 2023. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that plays a critical role in supplying medical products to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,094.56 firm fixed-price delivery order is for the supply of 4568206773 - Sodium Phosphate 15 MMOL/5 ML 5ML. The contract has a performance period through May 12, 2025 and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999.00...
This federal contract award, with ID SPE2DB22D3301|SPE2DB24FX6VP, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of 4563063274 - SODIUM PHOSPHATE 15 MMOL/5 ML 5ML, with a ceiling value of $3,415.90 and a completion date of December 12, 2023. The contract is a Delivery Order with a Firm Fixed Price pricing type. No set-aside designation was used for this award. Amerisourcebergen Drug Corp is a major...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4563363537 - SODIUM PHOSPHATE 45 MMOL/15 ML 15ML. The $1,356.10 order has a completion date of January 22, 2024. Amerisourcebergen Drug Corp, through its Corporate Office division, is a prime contractor providing pharmaceutical products and medical supplies to support DLA Troop Support Medical programs and facilities. This...
This federal contract award, valued at $7,926.40, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4563702224 - Sodium Phosphate 45 MMOL/15 ML, a medical product, with a completion date of February 20, 2024. This is a Firm Fixed Price Delivery Order contract, and there is no set-aside designation indicated. Amerisourcebergen holds a significant Indefinite...
This contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the supply of a specific pharmaceutical product, 4565086472 - Sodium Phosphate 45 MMOL/15 ML 15ML, to the Defense Logistics Agency (DLA). The $8,339.90 firm fixed-price delivery order has a ceiling value and an ultimate completion date of July 9, 2024. The contract is not designated as a set-aside. Amerisourcebergen, a major pharmaceutical distribution company, holds a single-award Indefinite Delivery...
This federal contract award, valued at $1,244.91, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4555495394 - SODIUM PHOSPHATE 3MM/ML VIAL 15ML, a medical product used in federal healthcare programs. The award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen's parent company, Cencora, Inc., and the DLA Troop Support Medical,...
This federal contract award, with ID SPE2DB20D3103|SPE2DB23FP1Q7, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,500.22, is for the delivery of 4561635010 - Sodium Phosphate 15 MMOL/5 ML 5ML. The contract is a Delivery Order with a Firm Fixed Price pricing type, and the ultimate completion date is July 31, 2023. Amerisourcebergen Drug Corp holds significant...
This is a delivery order (SPE2DB22FL7G9) awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the procurement of "SODIUM PHOSPHATE 3MM/ML VIAL 15ML". The contract has a ceiling value of $1,244.91 and runs through November 23, 2021. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which also holds a separate Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical worth up to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,666.72 firm fixed-price delivery order is for the supply of 4,561,306,734 units of 15 mmol/5 ml sodium phosphate solution. The award is not designated as a set-aside contract. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, which serves as...
  • SPE2DB22D2206
    Indefinite Delivery Contract
  • SPE2DB22D2206-SPE2DB24FKL92
    Delivery Order

This federal contract award is for the supply of SODIUM PHOSPHATE 45 MMOL/15 ML 15ML to the Defense Logistics Agency (DLA). The award, valued at $8,819.54, was made to the Amerisourcebergen Drug Corp Corporate Office Division, a major pharmaceutical distributor in the United States. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025. This IDC enables the DLA to efficiently procure a comprehensive range of medical commodities, including prescription drugs and supplies, to support military treatment programs and facilities worldwide. The contract does not have a set-aside designation and is a Firm Fixed Price arrangement.

Generated 12/25/24, 9:15 AM